The operations of PLIVA HRVATSKA are managed by the Management Board, with Mihael Furjan as its President and Nikolina Dizdar Čehulić, Romana Šantar and Zoran Bunčić as its members. Each of the Management Board members is responsible for an individual segment of the company’s business operations.
President of the Management Board
Mihael Furjan is appointed as President of PLIVA's Management Board, effective 4 May 2015, and his responsibilities cover PLIVA's operations in Croatia and Southeast Europe. Mihael Furjan was born in 1973 in Zagreb. He graduated from the Faculty of Economics and Business, University of Zagreb, in 1996. Mr. Furjan started his career at PLIVA in 1997 as business analyst in Economic Affairs, and thereafter advanced to the position of Economic Affairs Manager and Operating Planning Manager in Marketing Department.
He developed his expertise in a number of areas in the pharmaceutical industry. He was appointed as Biotechnology Project Director in 2001, New Products Launch Manager in Strategic Marketing in 2003, and Senior Director European Corporate Products in Business Development in 2004 responsible for the overall product lifecycle, and European Project Management and Country Support. In 2009, after leaving PLIVA, he joined Hrvatska Pošta (Croatian Post). Since 2010 and before re-joining PLIVA he worked as Executive Director, International Product Portfolio, for a global generic company in Switzerland.
A Member of the Management Board and Chief Financial Officer
Nikolina Dizdar Čehulić was born in Karlovac in 1977. She graduated from the Faculty of Economics and Business, University of Zagreb, in 2000, and started her career at Arthur Andersen. In 2002, she moved to Ernst & Young after merger of two companies.
She joined PLIVA d.d. in 2004 as Senior Financial Analyst for Planning and Group Performance Management. Soon after that Mrs. Dizdar Čehulić became Planning and Performance Management Director, and in 2007, Group Controlling Director. In 2009, she moved to Teva’s European headquarters in Utrecht to become Head of Finance and Accounting, Teva Europe.
In 2010 she returned to Croatia and joined General Electric GBS where she occupied the position of the Regional Head for Southeast Europe.
On 4 November 2013, she rejoined PLIVA's team, and on 26 November became Chief Financial Officer and a member of the Management Board for finance. Mrs. Dizdar Čehulić is a certified accountant and a fellow member of the Association of Chartered and Certified Accountants (FCCA) in Great Britain. In 2014 she completed the Executive MBA studies at the Cotrugli Business School.
Member of the Management Board and Executive Director of Product Supply Croatia
Zoran Bunčić was born in Požega in 1962. He graduated from the Faculty of Chemical Engineering and Technology of the University of Zagreb in 1986. As one of PLIVA's scholarship holders, he joined PLIVA a year later as a technologist in the production of active pharmaceutical ingredients and soon advanced to the position of Vitamin C Production Plant Manager. From 1995 to 1998 he led the Project Team for the expansion of Vitamin C production capacities, after which he held the positions of API Development Director and API Technical Operations Director.
In 2001 he became API Division Director and thus responsible for its entire business operations. From December 2008 till December 2014 he has held the position of the Executive Director of TAPI Croatia within BU TAPI Europe, i.e. Teva's API Division. He became a member of the Management Board of PLIVA HRVATSKA d.o.o. in 2009. He is a member of several professional associations such as the CphI Innovation Committee.
Management Board Member and Site General Manager, TAPI Croatia
Romana Šantar was born in Rome in 1971. She graduated in pharmacy from the Faculty of Pharmacy and Biochemistry, University of Zagreb, in 1994. Romana joined Pliva in 1994 as a Process Engineer in the Engineering department. In 2000 she joined Global Operations as a Project Manager coordinating the activities for new product introductions up to product launch for all the EU and US sites.
After responsibility for the construction of the new facility for oral solid forms manufacturing and packaging, she was promoted to Senior Director, Manufacturing in 2004. Since then she has been successfully leading the Zagreb pharmaceutical production activities, including oral solid forms, sterile forms, creams and ointments, packaging of all dosage forms, automated and control systems, maintenance and drafting of production documentation. Since January 2015 she has been Site General Manager, TAPI Croatia.